Susquehanna International Group, LLP Alector, Inc. Put Options Transaction History

Susquehanna International Group, LLP

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$4.34 - $6.58 $329,840 - $500,080	76,000 Added 752.48%	86,100 $402,000
Q2 2024 Aug 15, 2024	BUY	$4.19 - $6.23 $42,319 - $62,923	10,100 New	10,100 $45,000
Q4 2023 Feb 14, 2024	BUY	$3.77 - $8.39 $89,726 - $199,682	23,800 Added 75.8%	55,200 $440,000
Q3 2023 Nov 14, 2023	BUY	$5.2 - $8.77 $163,280 - $275,378	31,400 New	31,400 $203,000
Q1 2023 May 16, 2023	SELL	$5.85 - $9.84 $395,460 - $665,184	-67,600 Reduced 67.6%	32,400 $200,000
Q4 2022 Feb 14, 2023	BUY	$6.88 - $9.55 $269,696 - $374,360	39,200 Added 64.47%	100,000 $923,000
Q3 2022 Nov 14, 2022	BUY	$8.19 - $13.2 $352,170 - $567,600	43,000 Added 241.57%	60,800 $575,000

168

57.8M

146K

90.8K

Ticker ALEC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 82,563,904
Market Cap $154M
Description
Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.